Multi-omic Analysis and CRISPR Perturbation screens Identify Endothelial Cell Programs and Novel Therapeutic Targets for Coronary Artery Disease

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 43; no. 5; pp. 600 - 608
• Main Authors: Gupta, Rajat M., Schnitzler, Gavin, Fang, Shi, Lee-Kim, Vivian S., Barry, Aurelie
• Format: Journal Article
• Language: English
• Published: 30.03.2023
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/ATVBAHA.123.318328

Endothelial cells (EC) are an important mediator of atherosclerosis and vascular disease. Their exposure to atherogenic risk factors such as hypertension and serum cholesterol leads to endothelial dysfunction, and many disease-associated processes. Identifying which of these multiple EC functions is causally related to disease risk has been challenging. There is evidence from in vivo models and human sequencing studies that dysregulation of nitric oxide production directly affects risk of coronary artery disease (CAD). Human genetics can help prioritize the other EC functions with causal relationships because germline mutations are acquired at birth, and serve as a randomized test of which pathways affect disease risk. Though several CAD risk variants have been linked to EC function, this process has been slow and laborious. Unbiased analyses of EC dysfunction using multi-omic approaches promise to identify the causal genetic mechanisms responsible for vascular disease. Here we review the data from genomic, epigenomic, and transcriptomic studies that prioritize EC-specific causal pathways. New methods that CRISPR perturbation technology with genomic, epigenomic, and transcriptomic analysis promise to speed the characterization of disease-associated genetic variation. We summarize several recent studies in ECs which use high-throughput genetic perturbation to identify disease relevant pathways and novel mechanisms of disease. These genetically validated pathways can accelerate the identification of drug targets for the prevention and treatment of atherosclerosis.